Overview

Effect on Cognitive Function of a Treatment With Aripiprazole

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of Aripiprazole after 12 weeks of therapy for Schizophrenic patients.
Phase:
Phase 4
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborator:
Otsuka America Pharmaceutical
Treatments:
Aripiprazole